Both in Biotechnology
Editas Medicine vs Surrozen
Over the past year EDIT returned −12.7% and SRZN returned +122.4%; their daily moves had a correlation of 0.29.
EDIT −12.7% SRZN +122.4%Growth of $1, one year, split-adjusted
| Metric | EDIT | SRZN |
|---|---|---|
| Price | $2.67 | $29.04 |
| Market cap | $410.1M | $341.3M |
| Today | −8.87% | −1.43% |
| 1 month | +6.0% | −3.2% |
| 6 months | −7.9% | −13.6% |
| Year to date | +30.2% | +28.5% |
| 1 year | −12.2% | +113.7% |
| Revenue growth (YoY) | +232.3% | +408.6% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −153.3% | 640.8% |
| P/E (TTM) | — | — |
| Price / sales | 8.7× | 29.7× |
| Net cash | $155.9M | $102.0M |
| Dividend yield | — | — |
| Volatility (60d) | 81.4% | 174.0% |
| Short % of float | 25.7% | 37.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).